Among men with a PCa diagnosis (Table 10), based on the Molecular Effects of Nutritional Supplements (MENS) trial [196], three months of EPA and DHA supplementation did not induce changes in circulating PSA concentrations, compared with lycopene ONS. Here, KLK3 is linked to posterior cortical atrophy.